Dusan Stefoski to Intention to Treat Analysis
This is a "connection" page, showing publications Dusan Stefoski has written about Intention to Treat Analysis.
Connection Strength
0.035
-
Safety and efficacy of daclizumab in relapsing-remitting multiple sclerosis: 3-year results from the SELECTED open-label extension study. BMC Neurol. 2016 Jul 26; 16:117.
Score: 0.035
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.